KP Tissue (KPT) Price Target Cut to C$10.00

KP Tissue (TSE:KPT) had its target price lowered by Royal Bank of Canada from C$11.00 to C$10.00 in a research report issued on Friday. The brokerage currently has an “outperform” rating on the stock. Royal Bank of Canada’s price objective suggests a potential upside of 35.14% from the company’s current price.

Other analysts have also issued reports about the company. Desjardins cut their price target on KP Tissue from C$11.00 to C$10.00 in a research note on Monday. TD Securities cut their price target on KP Tissue from C$11.50 to C$11.00 in a research note on Friday, August 10th. CIBC lowered KP Tissue from an “outperform” rating to a “neutral” rating and set a C$10.00 price target on the stock. in a research note on Thursday, July 12th. Finally, National Bank Financial cut their price target on KP Tissue from C$9.50 to C$7.00 and set a “sector perform” rating on the stock in a research note on Tuesday, October 23rd. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. KP Tissue has a consensus rating of “Hold” and a consensus price target of C$9.58.

Shares of KPT stock traded up C$0.04 during mid-day trading on Friday, reaching C$7.40. 5,860 shares of the stock traded hands, compared to its average volume of 17,067. KP Tissue has a 1-year low of C$6.58 and a 1-year high of C$14.44.

KP Tissue (TSE:KPT) last announced its quarterly earnings results on Thursday, August 9th. The company reported C$0.08 EPS for the quarter, meeting the Zacks’ consensus estimate of C$0.08. Equities analysts predict that KP Tissue will post 0.527854234984183 EPS for the current year.

In related news, insider Ii Joseph Kruger acquired 3,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 28th. The shares were bought at an average cost of C$9.88 per share, with a total value of C$29,640.00. Over the last ninety days, insiders purchased 5,700 shares of company stock worth $56,565.

KP Tissue Company Profile

KP Tissue Inc, through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in North America. The company operates through three segments: Consumer Products, Away-From-Home, and Other. It offers bathroom and facial tissues, paper towels, and paper towels and napkins, as well as disposable wiping products and washroom dispensing systems.

Featured Article: Hedge Funds

Analyst Recommendations for KP Tissue (TSE:KPT)

Receive News & Ratings for KP Tissue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KP Tissue and related companies with's FREE daily email newsletter.

Leave a Reply